Skip to main content
European Health and Digital Executive Agency (HaDEA)
  • Call for proposals
  • Closed

Call for proposals to support Member States and relevant actors to implement relevant results of innovative public health research in vaccination against COVID-19

Details

Status
Closed
Reference
EU4H-2022-PJ-5
Publication date
15 December 2022
Opening date
Deadline model
Single-stage
Deadline date
16 March 2023, 17:00 (CET)
Programme Sector
  • Health
Programme
  • EU4Health
Tags
  • AWP
  • EU financing
  • EUFunded
  • HealthUnion
  • Medical research
  • Proposals
  • Public health

Description

HaDEA has relaunched a call for proposals under the EU4Health 2022 Annual Work Programme.

‘Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19’

The call includes:

  • Mapping public health evidence and research results on COVID-19 large-scale vaccination that could be relevant for uptake;
  • Identifying challenges and assess solutions based on country-specific factors;
  • Developing implementation plans based on the current pandemic context or future health crises;
  • Implementing the pilot activities in volunteering EU countries (e.g. training programmes for health professionals, awareness-raising campaigns to tackle vaccine hesitancy, health preparedness training programmes, infrastructure initiatives, dedicated events for the exchange of good practices, risk communication and community engagement etc.);
  • Identifying successful pilot activities that have a robust sustainability plan for continued implementation.

This action supports the policy priority to respond to the COVID-19 crisis and implements the EU4Health Programme’s general objective of protecting people in the Union from serious cross-border health threats.

More information is available on the call web page

Info session

HaDEA organised an info session about this call on 17 January 2023.

Watch the recordings.